Articles published by Navidea Biopharmaceuticals, Inc.
Navidea Biopharmaceuticals Announces Oral Ruling in Case Involving Attorney’s Fees
September 01, 2022
Via Business Wire
Tickers
NAVB
Via Business Wire
Tickers
NAVB
Via Business Wire
Tickers
NAVB
Via Business Wire
Tickers
NAVB
Via Business Wire
Tickers
NAVB
Via Business Wire
Tickers
NAVB
Via Business Wire
Tickers
NAVB
Navidea Biopharmaceuticals Announces Launch of Phase 3 Clinical Trial in Rheumatoid Arthritis
December 16, 2021
Via Business Wire
Tickers
NAVB
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|